May 18, 2018 - Which of these beaten-down biotech stocks is in better position to mount a strong comeback?
May 07, 2018 - Acadia - the setup.Acadia's pipeline in a word: pimavanserin.Acadia's stock price yo-yoed in April as NUPLAZID® safety concerns took center stage.Today's (5/4/18) earnings report and CC provide a posi
May 04, 2018 - First-quarter revenue growth has investors excited.
May 04, 2018 - ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2018 Earnings Conference Call May 04, 2018 8:30 AM ET Executives Elena Ridloff – Senior Vice President-Investor Relations Steve Davis – President and Chief
May 04, 2018 - ACADIA posted narrower than expected loss in the first quarter of 2018 and sales beat estimates.
May 01, 2018 - ACADIA (ACAD) is expected to release first-quarter 2018 results on May 8 and provide updates on its drug, Nuplazid.
Apr 26, 2018 - AstraZeneca suffers setback in latest lung-cancer combination study.FDA announces safety review of Nuplazid from Acadia Pharmaceuticals.Catabasis highlights new positive data for edasalonexent treatin
Apr 25, 2018 - Shares tumble after a major news outlet reports that the FDA is re-examining the safety profile of Acadia's drug Nuplazid. Here's what investors need to know.
Apr 25, 2018 - Today's fund in the spotlight, Baker Brothers, has been struggling of late but as long term investors they´ve chalked up an impressive track record.I provide a brief overview of this fund and remind r
Apr 20, 2018 - J.B. Hunt is a Buy.GrubHub has received a host of downgrades.Cramer prefers T-Mobile over Sprint.